These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 32942031)

  • 1. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD40 ligand expression in systemic lupus erythematosus.
    Crow MK; Kirou KA
    Curr Opin Rheumatol; 2001 Sep; 13(5):361-9. PubMed ID: 11604589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides.
    Yellin MJ; D'Agati V; Parkinson G; Han AS; Szema A; Baum D; Estes D; Szabolcs M; Chess L
    Arthritis Rheum; 1997 Jan; 40(1):124-34. PubMed ID: 9008608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus.
    Perper SJ; Westmoreland SV; Karman J; Twomey R; Seagal J; Wang R; McRae BL; Clarke SH
    J Immunol; 2019 Jul; 203(1):58-75. PubMed ID: 31109957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
    Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
    Marken J; Muralidharan S; Giltiay NV
    Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell Activation.
    Fang T; Li B; Li M; Zhang Y; Jing Z; Li Y; Xue T; Zhang Z; Fang W; Lin Z; Meng F; Li L; Yang Y; Zhang X; Liang X; Chen SN; Chen J; Zhang X
    Small Methods; 2023 Mar; 7(3):e2200925. PubMed ID: 36605001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD40 ligand in systemic lupus erythematosus.
    Yazdany J; Davis J
    Lupus; 2004; 13(5):377-80. PubMed ID: 15230296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-hydroxy butyrate dehydrogenase 2 deficiency aggravates systemic lupus erythematosus progression in a mouse model by promoting CD40 ligand demethylation.
    Yang B; Hou S; Zhao J; Li Y
    Bioengineered; 2022 Feb; 13(2):2685-2695. PubMed ID: 35001849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.
    Sidiropoulos PI; Boumpas DT
    Lupus; 2004; 13(5):391-7. PubMed ID: 15230298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARĪ³ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway.
    Oxer DS; Godoy LC; Borba E; Lima-Salgado T; Passos LA; Laurindo I; Kubo S; Barbeiro DF; Fernandes D; Laurindo FR; Velasco IT; Curi R; Bonfa E; Souza HP
    Lupus; 2011 May; 20(6):575-87. PubMed ID: 21415255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease.
    Higuchi T; Aiba Y; Nomura T; Matsuda J; Mochida K; Suzuki M; Kikutani H; Honjo T; Nishioka K; Tsubata T
    J Immunol; 2002 Jan; 168(1):9-12. PubMed ID: 11751940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases.
    Wu HH; Ralph KL; Sepuldeva E; Hansen G; Li H; Huang ZF; Liu D; Dziegelewski M; Ahlberg J; Frego L; Fogal S; van Tongeren S; Grimaldi C; Litzenberger T; Presky D; Singh S; Brodeur S; Kroe-Barrett R
    Int J Pharm; 2021 Nov; 609():121162. PubMed ID: 34624444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.
    Yellin MJ; Thienel U
    Curr Rheumatol Rep; 2000 Feb; 2(1):24-31. PubMed ID: 11123036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease.
    Kairaitis L; Wang Y; Zheng L; Tay YC; Wang Y; Harris DC
    Kidney Int; 2003 Oct; 64(4):1265-72. PubMed ID: 12969144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.
    Zheng L; Sinniah R; Hsu SI
    J Histochem Cytochem; 2008 May; 56(5):517-29. PubMed ID: 18285351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.